These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3678064)

  • 1. Serum phenobarbital concentration predictions by a personal computer software system.
    Gingery JW; Embil AS; Robinson JD; Jernigan JA
    Drug Intell Clin Pharm; 1987 Nov; 21(11):895-900. PubMed ID: 3678064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of serum gentamicin concentration predictions generated by a personal-computer software system.
    Robinson JD; Hatton RC; Russell WL; Klapp D; Lopez LM
    Clin Pharm; 1984; 3(5):509-16. PubMed ID: 6548429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer prediction of serum theophylline concentrations in ambulatory patients.
    Deci PA; Lopez LM; Robinson JD; Grauer K
    Ther Drug Monit; 1985; 7(4):421-5. PubMed ID: 3841237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenobarbital in intensive care unit pediatric population: predictive performances of population pharmacokinetic model.
    Marsot A; Michel F; Chasseloup E; Paut O; Guilhaumou R; Blin O
    Fundam Clin Pharmacol; 2017 Oct; 31(5):558-566. PubMed ID: 28407406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of coadministered antiepileptic drugs on serum phenobarbital concentrations in epileptic patients: quantitative analysis based on a suitable transforming factor.
    Fukuoka N; Tsukamoto T; Uno J; Kimura M; Morita S
    Biol Pharm Bull; 2004 Dec; 27(12):2000-5. PubMed ID: 15577220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
    Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
    Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenobarbitone population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
    Yukawa E; Higuchi S; Aoyama T
    J Pharm Pharmacol; 1992 Sep; 44(9):755-60. PubMed ID: 1360529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualizing phenobarbital dosing in neonates.
    Gilman ME; Toback JW; Gal P; Erkan NV
    Clin Pharm; 1983; 2(3):258-62. PubMed ID: 6883954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and clinical effect of phenobarbital in children with severe falciparum malaria and convulsions.
    Kokwaro GO; Ogutu BR; Muchohi SN; Otieno GO; Newton CR
    Br J Clin Pharmacol; 2003 Oct; 56(4):453-7. PubMed ID: 12968992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of steady-state trough serum procainamide concentrations after administration of a sustained-release procainamide preparation.
    Voelker MS; Nester TJ; Chow MS; O'Reilly D; Kluger J
    Ther Drug Monit; 1986; 8(2):184-8. PubMed ID: 3726932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of initial phenobarbital dosing in term neonates with moderate-to-severe hypoxic ischaemic encephalopathy following perinatal asphyxia.
    Šíma M; Pokorná P; Hartinger J; Slanař O
    J Clin Pharm Ther; 2018 Apr; 43(2):196-201. PubMed ID: 28940525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of chloramphenicol with phenytoin and phenobarbital. Case report.
    Koup JR; Gibaldi M; McNamara P; Hilligoss DM; Colburn WA; Bruck E
    Clin Pharmacol Ther; 1978 Nov; 24(5):571-5. PubMed ID: 699481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years.
    Schoemaker R; Wade JR; Stockis A
    Eur J Clin Pharmacol; 2017 Jun; 73(6):727-733. PubMed ID: 28280887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenobarbital pharmacokinetics in obesity. A case report.
    Wilkes L; Danziger LH; Rodvold KA
    Clin Pharmacokinet; 1992 Jun; 22(6):481-4. PubMed ID: 1587059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic investigation of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants.
    Yukawa E; Suematsu F; Yukawa M; Minemoto M
    J Clin Pharm Ther; 2005 Apr; 30(2):159-63. PubMed ID: 15811169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenobarbital plasma level/dose ratio in monotherapy. Influence of age, sex and dose.
    Durán JA; Sánchez A; Serrano MI; Serrano JS
    Methods Find Exp Clin Pharmacol; 1988 May; 10(5):337-40. PubMed ID: 3398650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive capacity of carbamazepine pharmacokinetic parameters in a Portuguese outpatient population.
    Falcão AC; de Almeida AM; Leitão F; Santos J; Sales F; Caramona MM
    Ther Drug Monit; 1999 Apr; 21(2):224-30. PubMed ID: 10217344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased phenobarbital absorption with charcoal administration for chronic renal failure.
    Tanaka C; Yagi H; Sakamoto M; Koyama Y; Ohmura T; Ohtani H; Sawada Y
    Ann Pharmacother; 2004 Jan; 38(1):73-6. PubMed ID: 14742799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
    Edginton AN; Schmitt W; Willmann S
    Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of five methods for predicting phenobarbital concentrations in pediatric patients.
    Beck DE; Ravis WR; Snead OC
    Clin Pharm; 1986 Sep; 5(9):754-9. PubMed ID: 3757446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.